Attenuated live varicella virus vaccine (Merck Sharp & Dohme)

水痘病毒减毒活疫苗(默沙东)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAttenuated live varicella virus vaccine (Merck Sharp & Dohme)
Drug Alias NameVarivax
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsChickenpoxVaricella Zoster Virus Infection
Global Approved IndicationsVaricella Zoster Virus Infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1995/03/17
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsChickenpox

Other Information

ATC CodeJ07BK01
Related LinksWikipedia